Table 3B Multivariate analysis adjusted for anatomoclinical parameters (tumour location, stage, grade, and adjuvant chemotherapy) for patients without preop-RT (model based on 156 patients because of missing value for two patients)

From: Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II–III colorectal cancer

  

Relapse-free survival

Overall survival

 

n

HR

95% CI

P

HR

95% CI

P

CD57

CD57 ⩽2 cells per spot

100

2.7

1.3–5.7

 

2.3

1.1–4.8

 

CD57 >2 cells per spot

56

1

 

0.011

1

 

0.026

CD68

CD68=0 cells per spot

8

3.6

1.4–9.1

 

5.3

2.1–13.6

 

1⩽ CD68 ⩽10 cells per spot

55

1.2

0.6–2.3

 

1.6

0.9–3.0

 

CD68 >10 cells per spot

93

1

 

0.03

1

 

0.002

  1. Abbreviations: CI=confidence interval; HR=hazard ratio.
Back to article page